TY - JOUR
T1 - Prostate cancer early detection, Version 2.2016
T2 - Featured updates to the NCCN guidelines
AU - Carroll, Peter R.
AU - Parsons, J. Kellogg
AU - Andriole, Gerald
AU - Bahnson, Robert R.
AU - Castle, Erik P.
AU - Catalona, William J.
AU - Dahl, Douglas M.
AU - Davis, John W.
AU - Epstein, Jonathan I.
AU - Etzioni, Ruth B.
AU - Farrington, Thomas
AU - Hemstreet, George P.
AU - Kawachi, Mark H.
AU - Kim, Simon
AU - Lange, Paul H.
AU - Loughlin, Kevin R.
AU - Lowrance, William
AU - Maroni, Paul
AU - Mohler, James
AU - Morgan, Todd M.
AU - Moses, Kelvin A.
AU - Nadler, Robert B.
AU - Poch, Michael
AU - Scales, Chuck
AU - Shaneyfelt, Terrence M.
AU - Smaldone, Marc C.
AU - Sonn, Geoffrey
AU - Sprenkle, Preston
AU - Vickers, Andrew J.
AU - Wake, Robert
AU - Shead, Dorothy A.
AU - Freedman-Cass, Deborah A.
N1 - Publisher Copyright:
© JNCCN-Journal of tha National Comprehensive Cancer Network.
PY - 2016/5/1
Y1 - 2016/5/1
N2 - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.
AB - The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Prostate Cancer Early Detection provide recommendations for prostate cancer screening in healthy men who have elected to participate in an early detection program. The NCCN Guidelines focus on minimizing unnecessary procedures and limiting the detection of indolent disease. These NCCN Guidelines Insights summarize the NCCN Prostate Cancer Early Detection Panel's most significant discussions for the 2016 guideline update, which included issues surrounding screening in high-risk populations (ie, African Americans, BRCA1/2 mutation carriers), approaches to refine patient selection for initial and repeat biopsies, and approaches to improve biopsy specificity.
UR - http://www.scopus.com/inward/record.url?scp=84968764427&partnerID=8YFLogxK
U2 - 10.6004/jnccn.2016.0060
DO - 10.6004/jnccn.2016.0060
M3 - Review article
C2 - 27160230
AN - SCOPUS:84968764427
SN - 1540-1405
VL - 14
SP - 509
EP - 519
JO - JNCCN Journal of the National Comprehensive Cancer Network
JF - JNCCN Journal of the National Comprehensive Cancer Network
IS - 5
ER -